POLISCOPE
Topic15 documents tagged

Pharmaceutical Industry

What This Page Covers

This page collects the 15 public records POLISCOPE has tagged with “Pharmaceutical Industry”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Prescription Drugs, Healthcare Costs, and Drug Pricing.

Active Bills

State BillNEW JERSEYJan 13, 2026New Jersey requires state licensure and reporting for pharmaceutical sales representativesNew Jersey requires pharmaceutical sales representatives to obtain a state license from the State Board of Medical Examiners, complete annual continuing education, and periodically report all practitiFederal BillFEDERALDec 17, 2024Lower Drug Costs for Families Act (H.R. 4115)

Recent Activity

  1. Thu, May 71 item
    1. Trump Administration Drug Price Initiatives: What Has Changed?The Trump administration has launched several initiatives, including the 'TrumpRx' discount portal, aimed at lowering prescription drug costs. While some patients may see savings on specific medicatioUnited States
  2. Tue, May 51 item
    1. White House Projects $529 Billion in Savings from New Drug Pricing DealsThe White House estimates that new agreements with pharmaceutical companies to align U.S. drug prices with international rates could save $529 billion over the next decade. While the administration toUnited States

Finance Signals

No finance signals found for this topic in the available records yet.

Trace money trail →

Open the Money page to search by entity, donor, or PAC.

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01Bernie Sandersperson2 mentions
  2. 02Donald Trumpperson2 mentions
  3. 03Pfizerorganization2 mentions
  4. 04Committee on Oversight and Reformorganization2 mentions
  5. 05Mark Merrittperson2 mentions
  6. 06Aaron Kesselheimperson2 mentions
  7. 07Ron Wydenperson2 mentions
  8. 08Express Scriptsorganization2 mentions
  9. 09Albert Bourlaperson2 mentions
  10. 10Sackler familyperson1 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsNew Jersey requires state licensure and reporting for pharmaceutical sales representatives, Lower Drug Costs for Families Act (H.R. 4115)
  • Topic to peopleBernie Sanders, Donald Trump, Mark Merritt (+4 more)
  • Topic to orgsPfizer, Committee on Oversight and Reform, Express Scripts
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. May 7, 2026NewsTrump Administration Drug Price Initiatives: What Has Changed?
  2. May 5, 2026NewsWhite House Projects $529 Billion in Savings from New Drug Pricing Deals
  3. Jan 13, 2026State BillNew Jersey requires state licensure and reporting for pharmaceutical sales representatives
  4. Dec 17, 2024Federal BillLower Drug Costs for Families Act (H.R. 4115)
  5. Jan 1, 2022hearing transcriptCongressional Hearing on Prescription Drug Supply Chain and Pricing
  6. Jan 1, 2022hearing transcriptSenate Hearing on Sudden Price Spikes for Off-Patent Drugs
  7. Jan 1, 2022hearing transcriptSenate Hearing: Why U.S. Prescription Drug Prices Are the Highest in the World
  8. Jan 1, 2022hearing transcriptCorrection to Congressional Hearing Transcript on Purdue Pharma
  9. Jan 1, 2020hearing transcriptCongressional Hearing on Rising Insulin Costs
  10. Jan 1, 2019hearing transcriptSenate Hearing on Prescription Drug Costs and Delivery Systems

Showing 10 of 15 source records.